Showing 441 - 460 results of 801 for search '"insulin resistance"', query time: 0.07s Refine Results
  1. 441

    Posttransplant Metabolic Syndrome by M. Shadab Siddiqui, Richard K. Sterling

    Published 2012-01-01
    “…Metabolic syndrome (MS) is a cluster of metabolic derangements associated with insulin resistance and an increased risk of cardiovascular mortality. …”
    Get full text
    Article
  2. 442

    Stress in Obesity and Associated Metabolic and Cardiovascular Disorders by Paul Holvoet

    Published 2012-01-01
    “…This syndrome is a common and complex disorder combining obesity, dyslipidemia, hypertension, and insulin resistance. It is associated with high atherosclerotic cardiovascular risk, which can only partially be explained by its components. …”
    Get full text
    Article
  3. 443

    Putative Factors That May Modulate the Effect of Exercise on Liver Fat: Insights from Animal Studies by Faidon Magkos

    Published 2012-01-01
    “…An increase in intrahepatic triglyceride (IHTG) content is the hallmark of nonalcoholic fatty liver disease (NAFLD) and is strongly associated with insulin resistance and dyslipidemia. Although regular aerobic exercise improves metabolic function, its role in regulating fat accumulation in the liver is incompletely understood, and human data are scarce. …”
    Get full text
    Article
  4. 444
  5. 445

    Effect of antioxidant capsule supplementation on oxidative stress markers in hypertensive patients by Novaes-Gaeta Ludmila N., Moraes Mariele C., Katayama Keyla Y., Sangaletti Carine T., Irigoyen Maria Claudia, Freitas Sarah, Viana Ariane, de Angelis Katia, Caldini Elia G., Lopes Heno F.

    Published 2024-01-01
    “…A significant intragroup difference in homeostatic model assessment of insulin resistance (HOMAir) was noted between normotensive and hypertensive individuals at different times. …”
    Get full text
    Article
  6. 446

    Zinc Transporters, Mechanisms of Action and Therapeutic Utility: Implications for Type 2 Diabetes Mellitus by Stephen A. Myers, Alex Nield, Mark Myers

    Published 2012-01-01
    “…This previously unexplored concept would raise a whole new area of research into the pathophysiology of insulin resistance and introduce a new class of drug target with utility for diabetes pharmacotherapy.…”
    Get full text
    Article
  7. 447

    Potential Mechanisms of Exercise in Gestational Diabetes by Saeid Golbidi, Ismail Laher

    Published 2013-01-01
    “…Weight gain in pregnancy causes increased release of adipokines from adipose tissue; many adipokines increase oxidative stress and insulin resistance. Increased intramyocellular lipids also increase cellular oxidative stress with subsequent generation of reactive oxygen species. …”
    Get full text
    Article
  8. 448

    Reverse epidemiology of obesity paradox: Fact or fiction? by Bellamkonda K. Kishore

    Published 2024-11-01
    “…Evidence suggests that the development of obesity and insulin resistance are influenced by genetic (or ethnic) make up and dietary habits (culture) of the individuals. …”
    Get full text
    Article
  9. 449

    FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology by Yusuke Murata, Morichika Konishi, Nobuyuki Itoh

    Published 2011-01-01
    “…Serum FGF21 levels are increased in patients with metabolic diseases having insulin resistance, indicating that FGF21 is a metabolic regulator and a biomarker for these diseases.…”
    Get full text
    Article
  10. 450

    Defects in skeletal muscle subsarcolemmal mitochondria in a non-obese model of type 2 diabetes mellitus. by Nicola Lai, China Kummitha, Charles Hoppel

    Published 2017-01-01
    “…Diabetes and obesity are reported to have a selective effect on the function of subsarcolemmal and interfibrillar mitochondria in insulin-resistant skeletal muscle. The current study investigated the role of the subpopulations of mitochondria in the pathogenesis of insulin resistance in the absence of obesity. …”
    Get full text
    Article
  11. 451

    Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand? by Ivana Mikolasevic, Tajana Pavic, Tajana Filipec Kanizaj, Darija Vranesic Bender, Viktor Domislovic, Zeljko Krznaric

    Published 2020-01-01
    “…Crucial mechanisms involved in sarcopenia-nonalcoholic fatty liver disease (NAFLD) interplay are based on effects of insulin resistance, chronic inflammation, oxidative stress, and crosstalk between organs by secretion of cytokines (hepatokines, adipokines, and myokines). …”
    Get full text
    Article
  12. 452

    Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility by James Butterworth, Jean Deguara, Cynthia-Michelle Borg

    Published 2016-01-01
    “…Visceral obesity and insulin resistance are key pathophysiological mechanisms behind PCOS. …”
    Get full text
    Article
  13. 453

    Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue by Sofia Dias, Sílvia Paredes, Laura Ribeiro

    Published 2018-01-01
    “…Metabolic syndrome can be defined as a state of disturbed metabolic homeostasis characterized by visceral obesity, atherogenic dyslipidemia, arterial hypertension, and insulin resistance. The growing prevalence of metabolic syndrome will certainly contribute to the burden of cardiovascular disease. …”
    Get full text
    Article
  14. 454

    JAK inhibitors: a new choice for diabetes mellitus? by Mengjun Zhou, Qi Shen, Bo Li

    Published 2025-01-01
    “…In vivo and in vitro experimental studies have elucidated some of the mechanisms behind this effect, which seem to be based mainly on the reduction in β-cell disruption and the improvement of insulin resistance. In this review, we briefly describe the beneficial effects of JAK inhibitors among nonreceptor tyrosine kinase inhibitors for the treatment of DM and attempt to analyze the mechanisms involved.…”
    Get full text
    Article
  15. 455

    Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice by Jie Bai, Qiu-Yue Lin, Xiangbo An, Shuang Liu, Yao Wang, Yunpeng Xie, Jiawei Liao

    Published 2022-01-01
    “…Our data showed that GA administration by oral gavage at a daily dosage of 20 mg/kg body weight did not significantly ameliorate WTD-induced hyperlipidemia, hepatosteatosis, adipogenesis, or insulin resistance; furthermore, GA administration did not significantly ameliorate WTD-induced atherosclerosis. …”
    Get full text
    Article
  16. 456

    Spatiotemporal Regulators for Insulin-Stimulated GLUT4 Vesicle Exocytosis by Xiaoxu Zhou, Ping Shentu, Yingke Xu

    Published 2017-01-01
    “…Importantly, the dysfunction of insulin-regulated GLUT4 trafficking is strongly linked with peripheral insulin resistance and type 2 diabetes in human. The insulin signaling pathway, key signaling molecules involved, and precise trafficking itinerary of GSVs are largely identified. …”
    Get full text
    Article
  17. 457

    Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies by Franklyn Nonso Iheagwam, Olawumi Toyin Iheagwam

    Published 2025-03-01
    “…Diabetes mellitus (DM) is a progressive metabolic disease characterised by high blood glucose due to autoimmune destruction of the β-islet of Langerhans or gradual development of insulin resistance and β-cell degeneration. Numerous risk factors, from genetic to environmental, are associated with this disease. …”
    Get full text
    Article
  18. 458

    Diabetes Mellitus Secondary to Acute Pancreatitis in a Child with Wolf-Hirschhorn Syndrome by Asma Deeb

    Published 2017-01-01
    “…She had negative autoantibodies and no signs of insulin resistance and her monogenic diabetes genetic testing was negative. …”
    Get full text
    Article
  19. 459

    BMI, HOMA-IR, and Fasting Blood Glucose Are Significant Predictors of Peripheral Nerve Dysfunction in Adult Overweight and Obese Nondiabetic Nepalese Individuals: A Study from Cent... by Lekhjung Thapa, P. V. S. Rana

    Published 2016-01-01
    “…Homeostatic model assessment of insulin resistance (HOMA-IR) was the significant predictor (P=0.019, 96% CI = 1.420–49.322) of sensory nerve dysfunction. …”
    Get full text
    Article
  20. 460

    Methods and Models for Metabolic Assessment in Mice by G. Pacini, B. Omar, B. Ahrén

    Published 2013-01-01
    “…This report summarizes how these tests can be executed and how arising data are analyzed to confidently determine changes in insulin resistance and insulin secretion with high reproducibility. …”
    Get full text
    Article